Italia markets closed

ILMN May 2024 95.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,2500+0,1000 (+66,67%)
In data: 03:29PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,1500
Aperto0,2000
Denaro0,1500
Lettera0,3000
Prezzo d'esercizio95,00
Scadenza2024-05-31
Min-Max giorno0,2000 - 0,2700
Contratto - Min-MaxN/D
Volume10
Open Interest34
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera